Journal for ImmunoTherapy of Cancer (Nov 2020)

347 Clinical outcomes of ovarian cancer patients treated with ALKS 4230, a novel engineered cytokine, in combination with pembrolizumab: ARTISTRY-1 trial

  • Lucy Gilbert,
  • Jameel Muzaffar,
  • David McDermott,
  • Vamsidhar Velcheti,
  • Anna Spreafico,
  • Valentina Boni,
  • Christopher Hoimes,
  • Ira Winer,
  • Seth Rosen,
  • Quincy Chu,
  • Olivier Dumas,
  • Aman Chauhan,
  • Arvind Chaudhry,
  • Piotr Tomczak,
  • Debora Bruno,
  • Elizabeth Dorn,
  • Jessicca Rege

DOI
https://doi.org/10.1136/jitc-2020-SITC2020.0347
Journal volume & issue
Vol. 8, no. Suppl 3

Abstract

Read online

No abstracts available.